{"title":"安非他明:多年后仍有致幻作用","authors":"Lawrence H. Price M.D.","doi":"10.1002/pu.31254","DOIUrl":null,"url":null,"abstract":"<p>A few years ago, I found myself evaluating a clinic patient whose chief complaint was poor concentration, which he maintained was so severe that he could not even hold down a menial job. Fortunately, he was happy to provide me with his diagnosis (“ADHD”) and knew exactly which medication would eliminate his symptoms: amphetamine (I'm using the term broadly here to encompass the numerous pharmaceutical preparations of this drug that are currently available).</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 1","pages":"7"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Amphetamine: still psychotogenic after all these years\",\"authors\":\"Lawrence H. Price M.D.\",\"doi\":\"10.1002/pu.31254\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A few years ago, I found myself evaluating a clinic patient whose chief complaint was poor concentration, which he maintained was so severe that he could not even hold down a menial job. Fortunately, he was happy to provide me with his diagnosis (“ADHD”) and knew exactly which medication would eliminate his symptoms: amphetamine (I'm using the term broadly here to encompass the numerous pharmaceutical preparations of this drug that are currently available).</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"36 1\",\"pages\":\"7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31254\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31254","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Amphetamine: still psychotogenic after all these years
A few years ago, I found myself evaluating a clinic patient whose chief complaint was poor concentration, which he maintained was so severe that he could not even hold down a menial job. Fortunately, he was happy to provide me with his diagnosis (“ADHD”) and knew exactly which medication would eliminate his symptoms: amphetamine (I'm using the term broadly here to encompass the numerous pharmaceutical preparations of this drug that are currently available).